Global Tuberculosis Testing Market Report 2022: Rising the Prevalence of Drug-Resistant Tuberculosis Infection Driving Growth - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--Nov 14, 2022--

The "Global Tuberculosis Testing Market (2022-2027) by Test Type, End-Users, and Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering.

The Global Tuberculosis Testing Market is estimated to be USD 2.35 Bn in 2022 and is expected to reach USD 3.41 Bn by 2027, growing at a CAGR of 7.74%

Market Dynamics

Drivers

• Rising the Prevalence of Drug-Resistant Tuberculosis Infection
• Improvement in Bacteriological Confirmation
• Increase in Awareness Enabling Proper Management of the Diseases

Restraints

• Development of Advanced and Hybrid Technique of Multiple Disorder Detection

Opportunities

• Rising Demand for Improved and Technologically Advanced Tuberculosis Testing Procedures
• Growing Tuberculosis Awareness and Control Program

Challenges

• Shortage of Supply of TST Antigens in Various Regions

Market Segmentations

The Global Tuberculosis Testing Market is segmented based on Test Type, End-Users, and Geography.

• By Test Type, the market is classified into Culture Based Tests, Drug Susceptibility Testing, Nucleic Acid Testing, Radiography, and Smear Microscopy.
• By End-Users, the market is classified into Hospital and Laboratories.
• By Geography, the market is classified into Americas, Europe, Middle-East & Africa, and Asia-Pacific.

Competitive Quadrant

The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Ansoff Analysis

The report presents a detailed Ansoff matrix analysis for the Global Tuberculosis Testing Market. Ansoff Matrix, also known as the Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.

The analyst analyses the Global Tuberculosis Testing Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.

Based on the SWOT analysis conducted on the industry and industry players, the analyst has devised suitable strategies for market growth.

Key Topics Covered:

1 Report Description

2 Research Methodology

3 Executive Summary

4 Market Dynamics

5 Market Analysis

6 Global Tuberculosis Testing Market, By Test Type

7 Global Tuberculosis Testing Market, By End-Users

8 Americas' Tuberculosis Testing Market

9 Europe's Tuberculosis Testing Market

10 Middle East and Africa's Tuberculosis Testing Market

11 APAC's Tuberculosis Testing Market

12 Competitive Landscape

13 Company Profiles

14 Appendix

Companies Mentioned

• Abbott Laboratories
• Advacare Pharma
• Akonni Biosystems, Inc.
• Apollo Diagnostics
• Becton, Dickinson and Company
• bioMerieux SA
• Cepheid
• Creative Diagnostics
• Danaher Corp.
• EpiLAB
• F. Hoffmann-La Roche, Ltd.
• Foresight Group, LLP
• Hain Lifescience GmbH
• Hologic, Inc.
• Lionex Diagnostics & Therapeutics GmbH
• Otsuka Pharmaceutical Co., Ltd.
• Oxford Immunotec, Ltd.
• Qiagen
• Siemens Healthineers Ag
• Thermo Fisher Scientific, Inc.

For more information about this report visit https://www.researchandmarkets.com/r/5hhkuk

View source version on businesswire.com:https://www.businesswire.com/news/home/20221114005757/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: INFECTIOUS DISEASES BIOTECHNOLOGY PHARMACEUTICAL HEALTH

SOURCE: Research and Markets

Copyright Business Wire 2022.